1)西田輝夫:角膜テキスト.エルゼビア・ジャパン,東京,2010
2)Murakami J, Nishida T, Otori T et al:Coordinated appearance of beta 1 integrins and fibronectin during corneal wound healing. J Lab Clin Med 120:86-93, 1992
3)Fujikawa LS, Foster CS, Harrist TJ et al:Fibronectin in wound healing rabbit corneal wounds. Lab Invest 45:120-129, 1981
4)Suda T, Nishida T, Ohashi Y et al:Fibronectin appears at the site of corneal stromal wound in rabbits. Curr Eye Res 1:553-556, 1981
5)Grushkin-Lerner LS, Trinkaus-Randall V:Localization of integrin and syndecan in vivo in a corneal epithelial abrasion and keratectomy. Curr Eye Res 10:75-85, 1991
6)Paallysaho T, Williams DS:Epithelial cell-substrate adhesion in the cornea:localization of actin, talin, integrin, and fibronectin. Exp Eye Res 52:261-267, 1991
7)Nishida T, Nakamura M, Mishima H et al:Differential modes of action of fibronectin and epidermal growth factor on rabbit corneal epithelial migration. J Cell Physiol 145:549-554, 1990
8)Nishida T, Nakamura M, Mishima H et al:Interleukin 6 facilitates corneal epithelial wound closure in vivo. Arch Ophthalmol 110:1292-1294, 1992
9)Nakamura M, Nishida T, Ofuji K et al:Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res 65:321-329, 1997
10)Nishida T, Nakamura M, Ofuji K et al:Synergistic effects of substance P with insulin-like growth factor 1 on epithelial migration of the cornea. J Cell Physiol 169:159-166, 1996
11)Nakamura M, Nishida T, Hikida M et al:Combined effects of hyaluronan and fibronectin on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res 13:385-388, 1994
12)Nishida T, Ohashi Y, Awata T et al:Fibronectin. A new therapy for corneal trophic ulcer. Arch Ophthalmol 101:1046-1048, 1983
13)Nishida T, Nakagawa S, Manabe R:Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratis. Ophthalmology 92:213-216, 1985
14)Brown SM, Lamberts DW, Reid TW et al:Neurotrophic and anhidrotic keratopathy treated with substance P and insulin-like growth factor 1. Arch Ophthalmol 115:926-927, 1997
15)Tsubota K, Goto E, Shimmura S et al:Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106:1984-1989, 1999
16)Tsubota K, Goto E, Fujita H et al:Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 83:390-395, 1999
17)Goto E, Shimmura S, Shimazaki J et al:Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20:807-810, 2001
18)Poon AC, Geerling G, Dart JK et al:Autologous serum eyedrops for dry eyes and epithelial defects:clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188-1197, 2001
19)Ogawa Y, Okamoto S, Mori T et al:Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31:579-583, 2003
20)Matsumoto Y, Dogru M, Goto E et al:Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111:1115-1120, 2004
21)Kojima T, Ishida R, Dogru M et al:Effects of autonogous eyedrops in the treatment of severe dry eye disease:A prospective case-control study. Am J Ophthalmol 139:242-246, 2005
22)Noda-Tsuruya T, Asano-Kato N, Toda I et al:Autologous serum eye drops for dry eye after LASIK. J Refract Surg 22:61-66, 2006